J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50. The company’s shares opened today at p1,644. ...

GSK has turned to Brooke Shields to get the message out about shingles vaccination. The drugmaker has worked with the model and actor to talk to female celebrities and patients aged 50 years and ...

GSK plc (GSK, GSK.L) announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the ...

Benetton's Benetton Sans was also based on Gill Sans, while John Lewis and Tommy Hilfiger also based logos on the typeface.

Palisade Bio is fortifying its brand image. The California-based biotech on Monday unveiled a new logo and website design, ...

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.

An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...

After hours: September 18 at 7:36 PM EDT Loading Chart for GSK ...

Teva Pharmaceutical Industries Ltd. ADR 2.22% $20.57B ...